Hims & Hers Health (HIMS) reported Q4 earnings Monday of $0.11 per diluted share, up from $0.01 a year earlier.
Analysts polled by FactSet expected $0.11.
Revenue for the quarter ended Dec. 31 was $481.1 million, up from $246.6 million a year earlier.
Analysts surveyed by FactSet expected $470.3 million.
Gross margin was 77% for Q4, compared with 83% a year ago.
The company said it expects Q1 revenue to be between $520 million and $540 million. Analysts expected $497 million.
The company expects 2025 revenue of $2.3 billion to $2.4 billion. Analysts expected $2.09 billion.
The shares were falling past 17% in after-hours activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。